Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Norgen Bioteck

Premium
Invitrogen launched its OptiCHO Express kit last week, designed “for the efficient growth and transfection of dihydrofolate reductase-deficient Chinese hamster ovary DG44 cells in suspension culture,” the company said.
 
The kit provides a complete workflow protocol for developing stable cell lines and includes components for expression vector construction, high-efficiency transfection of DG44 cells, and combinant protein expression in a serum-free environment with animal-free media, Invitrogen said.
 

 
Norgen Bioteck this week lauched its RNA/DNA/Protein Purification Kit. The kit allows researchers to isolate total RNA, genomic DNA, and proteins simultaneously from a single sample using one column, Norgen said. No additional supplemental protocols or acetone precipitation of proteins is needed, it said.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.